Effects of Coenzyme Q10 in Early Parkinson

Effects of Coenzyme Q10 in Early Parkinson Disease
Evidence of Slowing of the Functional Decline

Conclusions: Coenzyme Q10 was safe and well tolerated at dosages of up to 1200 mg/d. Less disability developed in subjects assigned to coenzymeQ10 than in those assigned to placebo, and the benefit was greatest in subjects receiving the highest dosage. Coenzyme Q10 appears to slow the progressive deterioration of function in PD, but these results need to be confirmed in a larger study.

Source: Arch Neurol. 2002;59:1541-1550